Mah Sing’s 1Q14 results were in line with expectations. 1Q14 salesstood at MYR770m. Although the annualised number is below management’s target of MYR3.6bn, we believe sales will pick up in the upcoming quarters in view of the projects in the pipeline. We maintain our BUY rating on the stock, at a higher FV of MYR2.50, as we include the incremental value of its recently acquired golf course land.
-
Within expectations. Mah Sing’s 1Q14 results came in within our and market expectations. The EBIT margin of 17% was lower compared with 20% in the same period last year due to the completion of some projects, and hence the writeback of over-provision of costs in 1Q13. Net gearing remained at a healthy 25%. As expected, no dividend was declared for the quarter.
-
MYR770m new sales in 1Q14. The company chalked up MYR770m in new sales in 1Q14 vs MYR700m in 4Q13. Although this is below management’s MYR3.6bn sales target on an annualised basis, the sales value was within our expectation and industry trend. This is because 4Q13-1Q14 was a challenging period for developers after cooling measures were announced, and as such, Mah Sing also did not launch as many projects. Sales in 1Q were largely from Savanna suites in Southville (MYR322m), Icon City (MYR121m) and D’sara Sentral SOVO(MYR116), while the 50% bookings for Lakeville Taman Wahyu and 77% for D’sara Sentral apartments will be gradually converted into sales in 2Q/3Q. Tomorrow, Mah Sing will preview the first phase of its 2½ and 3-storey garden linked homes with built-up areas of 2,988 and 3,438 sqf in Southville Bangi, which will be priced from MYR890k-1.2m. Other upcoming launches are Savanna Block 5 and Sierra Perdana in Johor.
-
Forecasts. We make no changes to our earnings forecasts. Unbilled sales continued to rise to MYR4.64bn in 1Q14 from MYR4.4bn in 4Q13.
-
Maintain BUY. We maintain our BUY call on the stock. As we include the incremental value from the recent acquisition of its golf course land in Shah Alam, we raise our FV slightly to MYR2.50 (from MYR2.44), based on an unchanged 15% discount to RNAV.
Source: RHB